Jennison Associates Trimmed Dte Energy Co (DTE) Position as Share Price Rose; Atlas Browninc Has Lowered Its Stake in Johnson & Johnson Com (JNJ) by $668,058 as Shares Rose

Johnson & Johnson (NYSE:JNJ) Logo

Jennison Associates Llc decreased its stake in Dte Energy Co (DTE) by 6.77% based on its latest 2018Q3 regulatory filing with the SEC. Jennison Associates Llc sold 91,050 shares as the company’s stock rose 5.21% while stock markets declined. The institutional investor held 1.25M shares of the central company at the end of 2018Q3, valued at $136.83M, down from 1.34M at the end of the previous reported quarter. Jennison Associates Llc who had been investing in Dte Energy Co for a number of months, seems to be less bullish one the $21.69 billion market cap company. The stock decreased 0.24% or $0.29 during the last trading session, reaching $119.2. About 748,954 shares traded. DTE Energy Company (NYSE:DTE) has risen 3.68% since February 13, 2018 and is uptrending. It has outperformed by 3.68% the S&P500. Some Historical DTE News: 30/05/2018 – Moody’s Changes Outlook Of Dte Gas To Negative; 30/03/2018 – DTE Energy: Projects Would Drive Investment of More Than $1.7B in Michigan; 30/04/2018 – Fitch Rates DTE Electric Co.’s $525MM Mtge Bonds ‘A+’; Outlook Negative; 30/03/2018 – DTE Energy Proposes $1.7 Billion Plan To Double Renewable Energy Capacity In Michigan — MarketWatch; 25/04/2018 – DTE Energy Backs 2018 View of Adj EPS $5.57-Adj EPS $5.99; 25/04/2018 – DTE ENERGY CO – REAFFIRMS 2018 OPERATING EPS GUIDANCE OF $5.57 – $5.99; 25/04/2018 – DTE ENERGY 1Q OPER EPS $1.91, EST. $1.90; 19/03/2018 – DTE Energy Affirms 2018 Operating Earnings Guidanc; 27/04/2018 – Michigan PSC: DTE Energy Foundation, DNR and ReLeaf Michigan partner to offer annual community tree-planting grants; 25/04/2018 – DTE ENERGY CO – FIRST QUARTER 2018 EARNINGS OF $361 MILLION, OR $2.00 PER DILUTED SHARE

Atlas Browninc decreased its stake in Johnson & Johnson Com (JNJ) by 12.31% based on its latest 2018Q3 regulatory filing with the SEC. Atlas Browninc sold 4,841 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 34,488 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $4.77 million, down from 39,329 at the end of the previous reported quarter. Atlas Browninc who had been investing in Johnson & Johnson Com for a number of months, seems to be less bullish one the $361.08 billion market cap company. The stock increased 0.35% or $0.47 during the last trading session, reaching $134.63. About 4.77 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 13, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 23/05/2018 – ADVISORY: JJ Ruest, CN interim president and chief executive officer, to address the Bernstein Strategic Decisions Conference i; 14/03/2018 – $JNJ highly-anticipated esketamine Ph3 data will be presented at #APAAM18 May 5-9 -; 15/05/2018 – STAT Plus: Pharmalittle: J&J and AbbVie roll back price hike after criticism; FDA to call out companies that thwart generics; 17/04/2018 – J&J – PLANS TO IMPLEMENT ACTIONS ACROSS ITS GLOBAL SUPPLY CHAIN; 29/05/2018 – Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference; 17/04/2018 – JNJ SAYS ACTELION IS DELIVERING AS EXPECTED; 15/03/2018 – JANSSEN PHARMACEUTICAL – BREAKTHROUGH THERAPY DESIGNATION BASED ON DATA FROM MULTICENTER, OPEN-LABEL PHASE 2 CLINICAL TRIAL OF ERDAFITINIB; 17/04/2018 – JNJ: PHARMA SEGMENT IS DRIVING UPBEAT OUTLOOK FOR 2018; 11/03/2018 – J&J Unit: Invokana Significantly Reduces Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease; 03/05/2018 – Protagonist Therapeutics Announces Oral Presentation Accepted for Digestive Diseases Week Conference

Since November 14, 2018, it had 0 insider purchases, and 3 selling transactions for $1.92 million activity. Jewell Jeffrey A sold 4,190 shares worth $502,800. Another trade for 1,850 shares valued at $219,540 was made by Oleksiak Peter B on Friday, November 16.

Among 11 analysts covering Dte Energy Company (NYSE:DTE), 4 have Buy rating, 2 Sell and 5 Hold. Therefore 36% are positive. Dte Energy Company has $12100 highest and $52 lowest target. $112’s average target is -6.04% below currents $119.2 stock price. Dte Energy Company had 39 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Underperform” rating on Monday, February 11 by Credit Suisse. The rating was maintained by Jefferies with “Buy” on Thursday, July 27. The firm has “Market Perform” rating by Wells Fargo given on Monday, June 11. The company was maintained on Friday, July 27 by KeyBanc Capital Markets. The stock of DTE Energy Company (NYSE:DTE) earned “Underperform” rating by Bank of America on Tuesday, February 20. KeyBanc Capital Markets maintained DTE Energy Company (NYSE:DTE) on Wednesday, October 18 with “Buy” rating. Wells Fargo maintained the stock with “Market Perform” rating in Monday, September 17 report. The rating was upgraded by Barclays Capital on Wednesday, January 13 to “Overweight”. The firm earned “Buy” rating on Tuesday, November 22 by Bank of America. The stock has “Buy” rating by UBS on Thursday, September 29.

Jennison Associates Llc, which manages about $108.60 billion US Long portfolio, upped its stake in Salesforce Com Inc (NYSE:CRM) by 8,629 shares to 16.63 million shares, valued at $2.64 billion in 2018Q3, according to the filing. It also increased its holding in Burlington Stores Inc (NYSE:BURL) by 48,575 shares in the quarter, for a total of 626,073 shares, and has risen its stake in Audentes Therapeutics Inc.

More notable recent DTE Energy Company (NYSE:DTE) news were published by: Prnewswire.com which released: “DTE invests $900,000 in electric safety education campaign for children, first responder training – PRNewswire” on January 18, 2019, also Finance.Yahoo.com with their article: “Is DTE Energy Company (DTE) Going to Burn These Hedge Funds? – Yahoo Finance” published on December 13, 2018, Seekingalpha.com published: “U.S. nat gas demand seen reaching record high during freeze – Seeking Alpha” on January 30, 2019. More interesting news about DTE Energy Company (NYSE:DTE) were released by: Globenewswire.com and their article: “Factors of Influence in 2019, Key Indicators and Opportunity within Fiserv, DTE Energy, Acacia Communications, Organovo, Presidio, and Power Integrations — New Research Emphasizes Economic Growth – GlobeNewswire” published on February 12, 2019 as well as Prnewswire.com‘s news article titled: “DTE Energy assists federal workers impacted by government shutdown – PRNewswire” with publication date: January 25, 2019.

Analysts await DTE Energy Company (NYSE:DTE) to report earnings on February, 15. They expect $0.95 EPS, down 24.60% or $0.31 from last year’s $1.26 per share. DTE’s profit will be $172.83M for 31.37 P/E if the $0.95 EPS becomes a reality. After $2.13 actual EPS reported by DTE Energy Company for the previous quarter, Wall Street now forecasts -55.40% negative EPS growth.

Investors sentiment increased to 1.25 in 2018 Q3. Its up 0.28, from 0.97 in 2018Q2. It improved, as 28 investors sold DTE shares while 149 reduced holdings. 75 funds opened positions while 146 raised stakes. 128.60 million shares or 2.08% more from 125.98 million shares in 2018Q2 were reported. Raymond James Service Advisors reported 0.02% stake. Dekabank Deutsche Girozentrale accumulated 0.13% or 196,379 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.04% or 39,405 shares in its portfolio. Ingalls Snyder Lc has invested 0.05% in DTE Energy Company (NYSE:DTE). Thomas White Intl Ltd invested 0.16% of its portfolio in DTE Energy Company (NYSE:DTE). Benjamin F Edwards Com Incorporated accumulated 100 shares. Jnba Fincl holds 0.01% or 300 shares in its portfolio. 3,846 are owned by Wellington Mgmt Gp Ltd Liability Partnership. Jpmorgan Chase And invested in 905,159 shares. Etrade Capital Mgmt Ltd Limited Liability Company reported 0.02% stake. Bessemer Inc holds 1,039 shares. Commonwealth Of Pennsylvania School Empls Retrmt holds 14,916 shares. Mufg Americas Corporation invested in 0% or 469 shares. 1,060 were reported by Amica Retiree. Symphony Asset Management Llc accumulated 3,860 shares.

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $136.12’s average target is 1.11% above currents $134.63 stock price. Johnson & Johnson had 111 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, June 12 the stock rating was maintained by Credit Suisse with “Buy”. As per Friday, July 14, the company rating was maintained by Jefferies. Credit Suisse maintained the shares of JNJ in report on Thursday, October 19 with “Buy” rating. The rating was maintained by BMO Capital Markets with “Buy” on Thursday, October 5. Morgan Stanley maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, January 2 with “Equal-Weight” rating. As per Tuesday, September 22, the company rating was initiated by UBS. The stock of Johnson & Johnson (NYSE:JNJ) has “Outperform” rating given on Friday, April 20 by Credit Suisse. Atlantic Securities initiated the shares of JNJ in report on Friday, December 18 with “Neutral” rating. Citigroup maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, February 27 with “Neutral” rating. The firm has “Buy” rating given on Tuesday, June 13 by Cowen & Co.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson: P/E Matters – Seeking Alpha” on January 17, 2019, also Investorplace.com with their article: “5 Top Stock Trades for Wednesday: JNJ, CMG, MO, EBAY – Investorplace.com” published on January 22, 2019, Seekingalpha.com published: “Johnson & Johnson to acquire Auris Health for $3.4B – Seeking Alpha” on February 13, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Benzinga.com and their article: “Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits (NYSE:JNJ) – Benzinga” published on February 13, 2019 as well as Seekingalpha.com‘s news article titled: “J&J teams up with Apple in heart health program – Seeking Alpha” with publication date: January 17, 2019.

Since August 27, 2018, it had 3 insider purchases, and 8 insider sales for $79.44 million activity. $3.91 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Sneed Michael E. The insider Duato Joaquin sold 40,000 shares worth $5.77M. On Friday, December 14 MULCAHY ANNE M bought $100,050 worth of Johnson & Johnson (NYSE:JNJ) or 748 shares. Kapusta Ronald A sold $536,638 worth of stock or 3,643 shares. Fasolo Peter had sold 166,695 shares worth $24.41 million on Monday, December 3. Shares for $133,910 were bought by PEREZ WILLIAM D on Friday, December 14.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart